Mechanistic Insights into the Binding of Class IIa HDAC Inhibitors toward Spinocerebellar Ataxia Type-2: A 3D-QSAR and Pharmacophore Modeling Approach. The gene discussed is HDAC9; the disease is spinocerebellar ataxia type 2.